Skip to main content

Corporate insider profile

Gilmore Neil O'Neill Insider Trades

Latest reported as CEO of Editas Medicine, Inc. (EDIT).

Purchase filings
0
Reported companies
1
Net open-market value
-$57,105.53
Latest transaction
Sep 3, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 3, 2026Editas Medicine, Inc. (EDIT)CEOSale5,124$3.04$15,563
Jun 3, 2026Editas Medicine, Inc. (EDIT)CEOSale15,380$2.70$41,543